| Phase 4 |
| NCT06457503 |
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With… |
Nasopharyngeal Cancer Recurrent |
Recruiting |
| Phase 3 |
| NCT07340515 |
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial |
Nasopharyngeal Carcinoma (NPC) |
Recruiting |
| NCT07177794 |
Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC |
Esophageal Cancer |
Recruiting |
| NCT05340491 |
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT06437977 |
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable… |
Stage II-III Non-small Cell Lung Cancer |
Recruiting |
| NCT07371897 |
Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial |
Head and Neck Squamous Cell Carcinoma HNSCC |
Not Yet Recruiting |
| NCT07540390 |
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC. |
Nasopharyngeal Carcinoma |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06984588 |
A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and… |
Non Small Cell Lung Cancer |
Active, Not Recruiting |
| NCT07608224 |
HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable… |
Urinary Bladder Neoplasms |
Not Yet Recruiting |
| Phase 2 |
| NCT07353723 |
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar… |
Head & Neck Cancer |
Recruiting |
| NCT07290621 |
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV)… |
Oropharyngeal Cancer |
Recruiting |
| NCT06592599 |
Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT06208826 |
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in… |
Head and Neck Cancer |
Recruiting |
| NCT07457359 |
Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer |
TNBC, Triple Negative Breast Cancer |
Recruiting |
| NCT05798845 |
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+)… |
NSCLC |
Recruiting |
| NCT07481058 |
KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line… |
Esophageal Squamous Cell Carcinoma (ESCC) |
Recruiting |
| NCT07423078 |
Window of Opportunity in Preserving Laryngeal Function Trial |
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) |
Recruiting |
| NCT07540533 |
A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy… |
Advanced Breast Cancer |
Recruiting |
| NCT07378306 |
FMD and Neoadjuvant Chemo-immunotherapy in TNBC |
Breast Cancer |
Recruiting |
| NCT03810339 |
Toripalimab（JS001） as Monotherapy in Participants With POLE or POLD-1 Mutated and… |
Solid Tumor |
Recruiting |
| NCT07209189 |
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head… |
Head and Neck Cancer |
Recruiting |
| NCT06323239 |
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT07571551 |
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma |
Clear Cell RCC |
Recruiting |
| NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
Ovarian Cancer |
Recruiting |
| NCT07309276 |
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With… |
Advanced Lung Cancer |
Recruiting |